Bo Dupont - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Area:
Immunology
Website:
https://www.the-asci.org/controllers/asci/AsciProfileController.php?pid=154335

173 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Boudreau JE, Liu XR, Zhao Z, Zhang A, Shultz LD, Greiner DL, Dupont B, Hsu KC. Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I. Immunity. PMID 27496730 DOI: 10.1016/J.Immuni.2016.07.005  0.438
2016 Hasan AN, Selvakumar A, Shabrova E, Liu XR, Afridi F, Heller G, Riviere I, Sadelain M, Dupont B, O'Reilly RJ. Soluble and membrane bound IL-15 Rα/IL-15 complexes mediate proliferation of high avidity central memory CD8(+) T-cells for adoptive immunotherapy of cancer and infections. Clinical and Experimental Immunology. PMID 27227483 DOI: 10.1111/Cei.12816  0.432
2013 Pittari G, Liu XR, Selvakumar A, Zhao Z, Merino E, Huse M, Chewning JH, Hsu KC, Dupont B. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand. Journal of Immunology (Baltimore, Md. : 1950). 190: 4650-60. PMID 23554313 DOI: 10.4049/jimmunol.1202120  0.311
2012 Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. The New England Journal of Medicine. 367: 805-16. PMID 22931314 DOI: 10.1056/Nejmoa1200503  0.453
2012 Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. The Journal of Clinical Investigation. 122: 3260-70. PMID 22863621 DOI: 10.1172/Jci62749  0.417
2012 Jelcić I, Hsu KC, Kakalacheva K, Breiden P, Dupont B, Uhrberg M, Martin R, Münz C, Lünemann JD. Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 951-8. PMID 22185807 DOI: 10.1177/1352458511431726  0.354
2011 Kawase T, Morishima Y, Malkki M, Gooley TA, Hsu KC, Dupont B, Bardy P, Madigral A, Bignon J-, Spellman S, Velardi A, Petersdorf EW. Universal Role for HLA-C and KIR2Dl Ligand Mismatch in Severe Acute Graft-Versus-Host Disease After Unrelated Donor Hematopoietic Stem Cell Transplantation (U-HSCT) in Japanese and Caucasian Transplant Recipients: An Analysis on Behalf of International Histocompatibility Working Group in Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.043  0.377
2011 Venstrom JM, Pittari G, Chewning J, Gooley TA, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC. Donor KIR2DS1 and KIR3DS1 Are Associated With Improved Outcomes Following Unrelated Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.019  0.343
2009 Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung NK, Hsu KC. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7330-4. PMID 19934297 DOI: 10.1158/1078-0432.Ccr-09-1720  0.584
2009 Hasan AN, Kollen WJ, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly RJ. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. Journal of Immunology (Baltimore, Md. : 1950). 183: 2837-50. PMID 19635907 DOI: 10.4049/Jimmunol.0804178  0.614
2009 Burt BM, Plitas G, Zhao Z, Bamboat ZM, Nguyen HM, Dupont B, DeMatteo RP. The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors. Journal of Immunology (Baltimore, Md. : 1950). 183: 1789-96. PMID 19587011 DOI: 10.4049/Jimmunol.0900541  0.373
2009 Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4467-74. PMID 19531622 DOI: 10.1158/1078-0432.Ccr-09-0582  0.385
2009 Bioley G, Guillaume P, Luescher I, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Valmori D, Ayyoub M. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 299-306. PMID 19118058 DOI: 10.1158/1078-0432.Ccr-08-1747  0.327
2009 Dupont B, Malkki M, Gooley T, Wang H, Zhao L, Bojesen S, Petersdorf E, Hansen J. Allelic Variation in TP53 and MDM2 DNA Repair Genes Constitute Genetic Risk Factors for Long-Term Survival in Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 15: 53. DOI: 10.1016/J.Bbmt.2008.12.166  0.307
2009 Venstrom JM, Gooley TA, Spellman SR, Hasan RS, Pring JA, Malkki M, Dupont B, Petersdorf EW, Hsu KC. Donor KIR 3DS1 is Associated with Less Acute GvHD Following Unrelated Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies Biology of Blood and Marrow Transplantation. 15: 14. DOI: 10.1016/J.Bbmt.2008.12.041  0.376
2008 Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD, Barlogie B, van Rhee F. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. British Journal of Haematology. 143: 641-53. PMID 18950462 DOI: 10.1111/J.1365-2141.2008.07340.X  0.417
2008 Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, Mohanakumar T, Hsu KC, Dupont B, Yokoyama WM. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proceedings of the National Academy of Sciences of the United States of America. 105: 3053-8. PMID 18287063 DOI: 10.1073/Pnas.0712229105  0.429
2008 Venstrom JM, Zheng J, Hasan RS, Danis KE, Cheung IY, Dupont B, Cheung NK, Hsu KC. Lack of HLA Class I Ligands for Autologous Inhibitory KIR Is Associated with Improved Survival Following Autologous Stem Cell Transplant for Children with Neuroblastoma. Blood. 112: 3322-3322. DOI: 10.1182/Blood.V112.11.3322.3322  0.393
2007 Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. Journal of Immunology (Baltimore, Md. : 1950). 179: 854-68. PMID 17617576 DOI: 10.4049/Jimmunol.179.2.854  0.371
2007 Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component. Tissue Antigens. 42-5. PMID 17445161 DOI: 10.1111/J.1399-0039.2006.759_5.X  0.318
2007 Chewning JH, Gudme CN, Heller G, Dupont B. The Activating KIR2DS2 Gene Influences NK Alloreactivity and NK Repertoire. Blood. 110: 313-313. DOI: 10.1182/Blood.V110.11.313.313  0.408
2007 Chewning J, Gudme C, Selvakumar A, Dupont B. 346: KIR2DS1 and 2DS2 induce NK cell cytokine response against allogeneic B-lymphoblastoid cell lines Biology of Blood and Marrow Transplantation. 13: 125. DOI: 10.1016/J.Bbmt.2006.12.351  0.362
2006 Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, et al. The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry Biology of Blood and Marrow Transplantation. 12: 876-884. PMID 16864058 DOI: 10.1016/J.Bbmt.2006.05.007  0.378
2006 Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 828-36. PMID 16864053 DOI: 10.1016/J.Bbmt.2006.04.008  0.436
2006 Chewning JH, Gudme CN, Dupont B. The Activating KIR Genes 2DS1 and 2DS2 Regulate NK Alloreactivity In Vitro. Blood. 108: 927-927. DOI: 10.1182/Blood.V108.11.927.927  0.438
2006 Jacobsen N, Dickmeiss E, Heilmann C, Madsen H, Svejgaard A, Dupont B, Ryder L. Boosting of thymic T lymphocyte maturation and export by infusion of T cell depleted donor peripheral blood stem cells to a scid patient with declining T lymphocyte counts after HLA mismatch allogeneic BMT Biology of Blood and Marrow Transplantation. 12: 128. DOI: 10.1016/J.Bbmt.2005.11.393  0.426
2005 Hsu KC, Dupont B. Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Seminars in Hematology. 42: 91-103. PMID 15846575 DOI: 10.1053/J.Seminhematol.2005.01.010  0.408
2005 Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 105: 4878-84. PMID 15731175 DOI: 10.1182/Blood-2004-12-4825  0.567
2005 Shi J, Szmania S, Rosen N, Moreno A, Walker R, DuPont B, Hsu K, Baxter-Lowe L, Shaughnessy J, Barlogie B, Cottler-Fox M, Tricot G, van Rhee F. Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM). Blood. 106: 3472-3472. DOI: 10.1182/Blood.V106.11.3472.3472  0.418
2004 Dupont B, Hsu KC. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Current Opinion in Immunology. 16: 634-43. PMID 15342011 DOI: 10.1016/J.Coi.2004.07.013  0.429
2004 Vyas YM, Maniar H, Lyddane CE, Sadelain M, Dupont B. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals Journal of Immunology. 173: 1571-1578. PMID 15265884 DOI: 10.4049/Jimmunol.173.3.1571  0.333
2004 Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ, et al. Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 172: 3289-96. PMID 14978137 DOI: 10.4049/Jimmunol.172.5.3289  0.37
2004 Prasad VK, Selvakumar A, Dastigir H, Boulad F, Small TN, Prockop S, Dupont B, O’Reilly RJ, Kernan NA. Ten allele high-resolution DNA typing has a direct impact on the disease free survival (DFS) in pediatric recipients of T-cell depleted (TCD) unrelated donor (URD) hematopoietic stem cell transplant (HCT) Biology of Blood and Marrow Transplantation. 10: 57. DOI: 10.1016/J.Bbmt.2003.12.293  0.389
2004 Hsu K, Taylor C, O’Reilly R, Horowitz M, Arkun K, Pinto C, DuPont B. AML patients lacking kir ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants Biology of Blood and Marrow Transplantation. 10: 7. DOI: 10.1016/J.Bbmt.2003.12.013  0.368
2003 Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). 171: 6891-9. PMID 14662896 DOI: 10.4049/Jimmunol.171.12.6891  0.523
2003 Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens. 62: 79-86. PMID 12859599 DOI: 10.1034/J.1399-0039.2003.00072.X  0.32
2003 Gnjatic S, Atanackovic D, Jäger E, Matsuo M, Selvakumar A, Altorki NK, Maki RG, Dupont B, Ritter G, Chen YT, Knuth A, Old LJ. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proceedings of the National Academy of Sciences of the United States of America. 100: 8862-7. PMID 12853579 DOI: 10.1073/Pnas.1133324100  0.416
2003 Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics. 55: 220-6. PMID 12838378 DOI: 10.1007/s00251-003-0571-z  0.32
2003 Marsh SGE, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein EA, Shilling H, Sepulveda CAG, Hsu KC, Wain H. Erratum: Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 (Human Immunology (2003) 64 (648)) Human Immunology. 64. DOI: 10.1016/S0198-8859(03)00131-9  0.335
2002 Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunological Reviews. 190: 40-52. PMID 12493005 DOI: 10.1034/J.1600-065X.2002.19004.X  0.302
2002 Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf E, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 2002. Tissue Antigens. 60: 407-64. PMID 12492818 DOI: 10.1034/J.1399-0039.2002.600509.X  0.327
2002 Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 2002. Human Immunology. 63: 1213-68. PMID 12480266 DOI: 10.1016/S0198-8859(02)00769-3  0.379
2002 Vyas YM, Maniar H, Dupont B. Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunological Reviews. 189: 161-78. PMID 12445273 DOI: 10.1034/J.1600-065X.2002.18914.X  0.367
2002 Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of Immunology (Baltimore, Md. : 1950). 169: 5118-29. PMID 12391228  0.413
2002 Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG, Dupont B, O'Reilly RJ. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 99: 1730-40. PMID 11861290 DOI: 10.1182/Blood.V99.5.1730  0.553
2001 Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, Burkhardt JK, Dupont B. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions Journal of Immunology. 167: 4358-4367. PMID 11591760 DOI: 10.4049/Jimmunol.167.8.4358  0.376
2001 Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 2000. Human Immunology. 62: 419-68. PMID 11295476 DOI: 10.1016/S0198-8859(01)00229-4  0.327
2000 Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proceedings of the National Academy of Sciences of the United States of America. 97: 10917-22. PMID 11005863 DOI: 10.1073/Pnas.97.20.10917  0.472
2000 Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America. 97: 4760-5. PMID 10781081 DOI: 10.1073/Pnas.97.9.4760  0.43
1999 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 1998. Tissue Antigens. 53: 407-46. PMID 10321590 DOI: 10.1034/J.1399-0039.1999.530421.X  0.327
1999 Vyas Y, Selvakumar A, Steffens U, Dupont B. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual. Tissue Antigens. 52: 510-9. PMID 9894849 DOI: 10.1111/J.1399-0039.1998.Tb03081.X  0.433
1998 King PD, Sadra A, Teng JM, Bell GM, Dupont B. CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. International Immunology. 10: 1009-16. PMID 9701039 DOI: 10.1093/Intimm/10.7.1009  0.331
1998 Steffens U, Vyas Y, Dupont B, Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens. 51: 398-413. PMID 9583814 DOI: 10.1111/J.1399-0039.1998.Tb02981.X  0.314
1997 August A, Sadra A, Dupont B, Hanafusa H. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proceedings of the National Academy of Sciences of the United States of America. 94: 11227-32. PMID 9326591 DOI: 10.1073/Pnas.94.21.11227  0.581
1997 Dupont B. Immunology of hematopoietic stem cell transplantation: a brief review of its history. Immunological Reviews. 157: 5-12. PMID 9255618 DOI: 10.1111/J.1600-065X.1997.Tb00970.X  0.314
1997 Selvakumar A, Staffens U, Palanisamy N, Chaganti RSK, Dupont B. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 Tissue Antigens. 49: 564-573. PMID 9234477 DOI: 10.1111/J.1399-0039.1997.Tb02803.X  0.36
1997 Dupont B, Selvakumar A, Steffens U. The killer cell inhibitory receptor genomic region on human chromosome 19q13.4. Tissue Antigens. 49: 557-63. PMID 9234476 DOI: 10.1111/J.1399-0039.1997.Tb02802.X  0.371
1997 Teng JM, King PD, Sadra A, Liu X, Han A, Selvakumar A, August A, Dupont B. Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion. Tissue Antigens. 48: 255-64. PMID 8946678 DOI: 10.1111/j.1399-0039.1996.tb02643.x  0.542
1997 King PD, Sadra A, Han A, Liu XR, Sunder-Plassmann R, Reinherz EL, Dupont B. CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. International Immunology. 8: 1707-14. PMID 8943565 DOI: 10.1093/Intimm/8.11.1707  0.377
1997 Dupont B. Histocompatibility testing for HLA class I Tissue Antigens. 50: 317-317. DOI: 10.1111/J.1399-0039.1997.Tb02879.X  0.326
1996 Ng J, Hurley CK, Carter C, Baxter-Lowe LA, Bing D, Chopek M, Hegland J, Lee TD, Li TC, Hsu S, KuKuruga D, Mason JM, Monos D, Noreen H, Rosner G, ... ... Dupont B, et al. Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2. Tissue Antigens. 47: 21-6. PMID 8929709 DOI: 10.1111/J.1399-0039.1996.Tb02510.X  0.342
1996 Gibson S, August A, Branch D, Dupont B, Mills GB. Functional LCK is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK Journal of Biological Chemistry. 271: 7079-7083. PMID 8636141 DOI: 10.1074/Jbc.271.12.7079  0.602
1996 August A, Dupont B. Association between mitogen-activated protein kinase and the ζ chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck: Differential regulation by TcR cross-linking Journal of Biological Chemistry. 271: 10054-10059. PMID 8626561 DOI: 10.1074/jbc.271.17.10054  0.542
1996 Kernan NA, Dupont B. Minor histocompatibility antigens and marrow transplantation. The New England Journal of Medicine. 334: 323-4. PMID 8532031 DOI: 10.1056/Nejm199602013340510  0.361
1996 Lucas K, Small T, Heller G, Dupont B, O'Reilly R. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation Blood. 87: 2594-2603. DOI: 10.1182/Blood.V87.6.2594.Bloodjournal8762594  0.572
1996 Petersdorf E, Hurley C, Dupont B, Begovitch A, Hansen J, Hartzman R, Kollman C, Nademanee A, McGlave P. Analysis of 595 marrow transplants for the treatment of chronic myeloid leukemia from unrelated donors facilitated by the US national marrow donor program (NMDP): Effect of HLA class II allele disparity on clinical outcome Human Immunology. 47: 80. DOI: 10.1016/0198-8859(96)85125-1  0.367
1996 Selvakumar A, Dupont B. P376 - Two new human nK receptors for HLA class I antigens Human Immunology. 47: 70. DOI: 10.1016/0198-8859(96)85071-3  0.362
1995 Dupont B. Phototyping" for HLA: the beginning of the end of HLA typing as we know it. Tissue Antigens. 46: 353-354. PMID 8838343 DOI: 10.1111/J.1399-0039.1995.Tb03126.X  0.357
1995 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR. Nomenclature for factors of the HLA system, 1995. Vox Sanguinis. 69: 359-72. PMID 8751309 DOI: 10.1111/J.1423-0410.1995.Tb00376.X  0.327
1995 August A, Dupont B. Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: Activation in cells lacking p56(lck) Tissue Antigens. 46: 155-162. PMID 8525474 DOI: 10.1111/j.1399-0039.1995.tb03114.x  0.58
1995 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR. Nomenclature for factors of the HLA system, 1995. Human Immunology. 43: 149-64. PMID 7591874 DOI: 10.1016/0198-8859(95)00071-B  0.327
1994 August A, Dupont B. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line Biochemical and Biophysical Research Communications. 199: 1466-1473. PMID 8147892 DOI: 10.1006/bbrc.1994.1396  0.566
1994 Mickelson EM, Bartsch GE, Hansen JA, Dupont B. The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers. Tissue Antigens. 42: 465-72. PMID 8146857 DOI: 10.1111/J.1399-0039.1993.Tb02190.X  0.391
1994 August A, Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase International Immunology. 6: 769-774. PMID 8080844 DOI: 10.1093/intimm/6.5.769  0.578
1994 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T. Nomenclature for factors of the HLA system, 1994. Tissue Antigens. 44: 1-18. PMID 7974464 DOI: 10.1111/J.1399-0039.1994.Tb02351.X  0.327
1994 August A, Gibson S, Kawakami Y, Kawakami T, Mills GB, Dupont B. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proceedings of the National Academy of Sciences of the United States of America. 91: 9347-51. PMID 7524075 DOI: 10.1073/Pnas.91.20.9347  0.582
1994 Lucas K, Small T, O'Reilly R, Dupont B. The effect of donor leukocyte infusions on development of EBV specific immunity post-marrow transplantation Human Immunology. 40: 29. DOI: 10.1016/0198-8859(94)91716-7  0.516
1994 August A, Dupont B. Triggering of the CD3 complex on T cells results in the recruitment of the guanine nucleotide exchange factor p95vav and the ZAP-70 tyrosine kinase Human Immunology. 40: 22. DOI: 10.1016/0198-8859(94)91703-5  0.565
1994 August A, Gibson S, Kawakami Y, Kawakami T, Mills G, Dupont B. Tyrosine phosphorylation and activation of the tec family kinase member emt/itk/tsk following CD28 and CD3 crosslinking Human Immunology. 40: 5. DOI: 10.1016/0198-8859(94)91669-1  0.559
1993 Ng J, Hurley CK, Baxter-Lowe LA, Chopek M, Coppo PA, Hagland J, KuKuruga D, Monos D, Rosner G, Schmeckpeper B, Yang SY, Dupont B, Hartzman RJ. Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable Tissue Antigens. 42: 473-479. PMID 8146858 DOI: 10.1111/J.1399-0039.1993.Tb02191.X  0.355
1993 Geisberg M, Dupont B. Cytolytic effector function is present in resting peripheral T lymphocytes. International Immunology. 4: 1273-81. PMID 1472478 DOI: 10.1093/Intimm/4.11.1273  0.408
1992 Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Show TB, White PC, Dupont B. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics. 36: 369-76. PMID 1526658 DOI: 10.1007/Bf00218044  0.337
1992 Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. The Journal of Clinical Investigation. 90: 229-37. PMID 1378854 DOI: 10.1172/Jci115840  0.335
1992 Selvakumar A, Mohanraj BK, Eddy RL, Shows TB, White PC, Dupont B. Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics. 36: 175-81. PMID 1377173 DOI: 10.1007/Bf00661094  0.342
1992 Geisberg M, Terry LA, Flomenberg N, Dupont B. Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity Human Immunology. 35: 239-245. PMID 1293087 DOI: 10.1016/0198-8859(92)90005-8  0.429
1991 Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. The New England Journal of Medicine. 323: 1818-22. PMID 2247120 DOI: 10.1056/Nejm199012273232607  0.56
1991 Koulova L, Clark EA, Shu G, Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells Journal of Experimental Medicine. 173: 759-762. PMID 1847724 DOI: 10.1084/JEM.173.3.759  0.318
1991 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T. Nomenclature for factors of the HLA system, 1990. Vox Sanguinis. 61: 147-55. PMID 1722369 DOI: 10.1111/J.1423-0410.1991.Tb00265.X  0.327
1990 Klein JL, Selvakumar A, Trapani JA, Dupont B. Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C) Tissue Antigens. 35: 220-228. PMID 2402757 DOI: 10.1111/J.1399-0039.1990.Tb01787.X  0.356
1990 Bodmer JG, Marsh SG, Parham P, Erlich HA, Albert E, Bodmer WF, Dupont B, Mach B, Mayr WR, Sasazuki T. Nomenclature for factors of the HLA system, 1989. Immunobiology. 180: 278-92. PMID 2111798 DOI: 10.1016/S0171-2985(11)80335-9  0.327
1990 Geisberg M, Trapani JA, Dupont B. Monoclonal antibodies detecting discrete epitopes of human perforin. Tissue Antigens. 35: 229-33. PMID 1698318 DOI: 10.1111/J.1399-0039.1990.Tb01788.X  0.358
1989 Kato K, Dupont B, Yang SY. Localization of nucleotide sequence which determines Mongoloid subtype of HLA-B13. Immunogenetics. 29: 117-120. PMID 2914710 DOI: 10.1007/Bf00395860  0.307
1989 Klein JL, Shows TB, Dupont B, Trapani JA. Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes Genomics. 5: 110-117. PMID 2788607 DOI: 10.1016/0888-7543(89)90093-1  0.302
1989 Mizuno S, Kang SH, Lee HW, Trapani JA, Dupont B, Yang SY. Isolation and expression of a cDNA clone encoding HLA-Cw6: unique characteristics of HLA-C encoded gene products Immunogenetics. 29: 323-330. PMID 2714853 DOI: 10.1007/Bf00352842  0.386
1989 Small TN, Keever C, Collins N, Dupont B, O'Reilly RJ, Flomenberg N. Characterization of B cells in severe combined immunodeficiency disease. Human Immunology. 25: 181-93. PMID 2670851 DOI: 10.1016/0198-8859(89)90081-5  0.54
1989 Frame JN, Collins NH, Cartagena T, Waldmann H, O'Reilly RJ, Dupont B, Kernan NA. T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation. 47: 984-8. PMID 2660360 DOI: 10.1097/00007890-198906000-00013  0.507
1989 Keever CA, Flomenberg N, Small T, Brochstein J, Collins N, Young-Yang S, Insel R, Dupont B, O'Reilly RJ. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease. Human Immunology. 26: 27-38. PMID 2528525 DOI: 10.1016/0198-8859(89)90030-X  0.624
1989 Bordignon C, Keever C, Small T, Flomenberg N, Dupont B, O'Reilly R, Kernan N. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms Blood. 74: 2237-2243. DOI: 10.1182/Blood.V74.6.2237.2237  0.606
1988 Trapani JA, Klein JL, White PC, Dupont B. Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes Proceedings of the National Academy of Sciences of the United States of America. 85: 6924-6928. PMID 3261871 DOI: 10.1073/Pnas.85.18.6924  0.327
1988 Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clinical Immunology and Immunopathology. 48: 261-76. PMID 3042210 DOI: 10.1016/0090-1229(88)90020-7  0.603
1988 Trapani J, Mizuno S, Yang S, Dupont B. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by monoclonal antibody 4E Human Immunology. 23: 153. DOI: 10.1016/0198-8859(88)90278-9  0.36
1988 Kato K, Dupont B, Yang SY. Nucleotide sequence analysis of oriental HLA-B13 Human Immunology. 23: 111. DOI: 10.1016/0198-8859(88)90178-4  0.313
1988 Kernan NA, Byers V, Scannon PJ, Mischak RP, Brochstein J, Flomenberg N, Dupont B, O'Reilly RJ. Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. Jama. 259: 3154-3157. DOI: 10.1001/Jama.1988.03720210044027  0.542
1987 Chouaib S, Robb RJ, Welte K, Dupont B. Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. Journal of Clinical Investigation. 80: 333-340. PMID 3038954 DOI: 10.1172/Jci113077  0.318
1987 Rosenkrantz K, Dupont B, Williams D, Flomenberg N. Autocytotoxic and autosuppressor T-cell lines generated from autologous lymphocyte cultures. Human Immunology. 19: 189-203. PMID 2957345 DOI: 10.1016/0198-8859(87)90069-3  0.378
1987 Bernard A, Knowles RW, Naito K, Dupont B, Raynal B, Tran HC, Boumsell L. A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions. Human Immunology. 17: 388-405. PMID 2432048 DOI: 10.1016/0198-8859(86)90299-5  0.385
1987 Kernan NA, Flomenberg N, Dupont B, OʼReilly RJ. GRAFT REJECTION IN RECIPIENTS OF T-CELL-DEPLETED HLA-NONIDENTICAL MARROW TRANSPLANTS FOR LEUKEMIA Transplantation. 43: 842-847. DOI: 10.1097/00007890-198706000-00014  0.515
1986 O'Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Kernan N, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sanguinis. 51: 81-6. PMID 3532540 DOI: 10.1111/J.1423-0410.1986.Tb02013.X  0.563
1986 Horibe K, Knowles RW, Dupont B. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules. Human Immunology. 16: 14-23. PMID 2423484 DOI: 10.1016/0198-8859(86)90032-7  0.416
1986 Pistillo MP, Hämmerling U, Dupont B, Ferrara GB. In vitro production of a human HLA alloantibody of restricted specificity (DQw2) via Epstein-Barr virus transformation. Human Immunology. 15: 109-17. PMID 2419282 DOI: 10.1016/0198-8859(86)90321-6  0.406
1986 Kernan N, Collins N, Juliano L, Cartagena T, Dupont B, O'Reilly R. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease Blood. 68: 770-773. DOI: 10.1182/Blood.V68.3.770.Bloodjournal683770  0.577
1985 White PC, New MI, Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proceedings of the National Academy of Sciences of the United States of America. 81: 7505-9. PMID 6334310 DOI: 10.1073/Pnas.81.23.7505  0.34
1985 White PC, Chaplin DD, Weis JH, Dupont B, New MI, Seidman JG. Two steroid 21-hydroxylase genes are located in the murine S region. Nature. 312: 465-7. PMID 6095106 DOI: 10.1038/312465A0  0.305
1985 Kernan NA, Flomenberg N, Collins NH, O'Reilly RJ, Dupont B. Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation. 40: 317-22. PMID 3875918 DOI: 10.1097/00007890-198509000-00019  0.483
1985 Myskowski PL, Pollack MS, Schorr E, Dupont B, Safai B. Human leukocyte antigen associations in basal cell carcinoma. Journal of the American Academy of Dermatology. 12: 997-1000. PMID 3874217 DOI: 10.1016/S0190-9622(85)70127-2  0.396
1985 Rosenkrantz K, Dupont B, Flomenberg N. Generation and regulation of autocytotoxicity in mixed lymphocyte cultures: evidence for active suppression of autocytotoxic cells. Proceedings of the National Academy of Sciences of the United States of America. 82: 4508-12. PMID 2989827 DOI: 10.1073/Pnas.82.13.4508  0.397
1985 White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proceedings of the National Academy of Sciences of the United States of America. 82: 1089-93. PMID 2983330 DOI: 10.1073/Pnas.82.4.1089  0.318
1985 Flomenberg N, Knowles RW, Williams D, Horibe K, Rosenkrantz K, Dupont B. T lymphocyte clones detecting novel supertypic HLA class II allospecificities. Immunogenetics. 22: 295-300. PMID 2412958 DOI: 10.1007/Bf00404490  0.378
1985 White PC, Dupont B, New MI. 872 CLONING OF cDNA ENCODING HUMAN STEROID 21-HYDROXYLASE Pediatric Research. 19: 256A-256A. DOI: 10.1203/00006450-198504000-00902  0.308
1985 Laster A, Palker T, Harden E, Ho W, Naito K, DuPont B, Haynes B. Antibody against T lymphoblastic leukemia-associated antigen (3-40) identifies vimentin and keratin intermediate filaments in normal cells Blood. 66: 642-648. DOI: 10.1182/Blood.V66.3.642.Bloodjournal663642  0.396
1984 Pollack MS, Gold J, Metroka CE, Safai B, Dupont B. HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections. Human Immunology. 11: 99-103. PMID 6333416 DOI: 10.1016/0198-8859(84)90048-X  0.337
1984 Broxmeyer HE, Juliano L, Lu L, Platzer E, Dupont B. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells. The Journal of Clinical Investigation. 73: 939-53. PMID 6231314 DOI: 10.1172/JCI111318  0.326
1984 Flomenberg N, Russo C, Ferrone S, Dupont B. HLA class I specific T lymphocyte clones with dual alloreactive functions. Immunogenetics. 19: 39-51. PMID 6229477 DOI: 10.1007/Bf00364474  0.431
1984 Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics. 19: 217-31. PMID 6200434 DOI: 10.1007/Bf00364765  0.379
1984 Flomenberg N, Naito K, Duffy E, Knowles RW, Evans RL, Dupont B. Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens. European Journal of Immunology. 13: 905-11. PMID 6196208 DOI: 10.1002/Eji.1830131109  0.416
1984 Popovic M, Flomenberg N, Volkman DJ, Mann D, Fauci AS, Dupont B, Gallo RC. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science (New York, N.Y.). 226: 459-62. PMID 6093248 DOI: 10.1126/Science.6093248  0.301
1983 Safai B, Myskowski PL, Dupont B, Pollack MS. Association of HLA-DR5 with mycosis fungoides. The Journal of Investigative Dermatology. 80: 395-7. PMID 6601679 DOI: 10.1111/1523-1747.Ep12553615  0.424
1983 Flomenberg N, Duffy E, Naito K, Dupont B. Two distinct phenotypes of HLA-DR-specific cytotoxic T-cell lines Immunogenetics. 17: 317-324. PMID 6601055 DOI: 10.1007/Bf00364415  0.422
1983 Naito K, Knowles R, Real F, Morishima Y, Kawashima K, Dupont B. Analysis of two new leukemia-associated antigens detected on human T- cell acute lymphoblastic leukemia using monoclonal antibodies Blood. 62: 852-865. DOI: 10.1182/Blood.V62.4.852.852  0.409
1983 Reisner Y, Kapoor N, Kirkpatrick D, Pollack M, Cunningham-Rundles S, Dupont B, Hodes M, Good R, O'Reilly R. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood. 61: 341-348. DOI: 10.1182/Blood.V61.2.341.Bloodjournal612341  0.591
1982 Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. The New England Journal of Medicine. 307: 662-6. PMID 7050708 DOI: 10.1056/Nejm198209093071106  0.564
1982 O'Neill GJ, Dupont B, Pollack MS, Levine LS, New MI. Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. Clinical Immunology and Immunopathology. 23: 312-22. PMID 6980755 DOI: 10.1016/0090-1229(82)90117-9  0.312
1982 Chan KW, Pollack MS, Braun D, O'Reilly RJ, Dupont B. Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Transplantation. 33: 613-5. PMID 6954756 DOI: 10.1097/00007890-198206000-00009  0.478
1982 Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 55: 817-27. PMID 6288753 DOI: 10.1210/Jcem-55-5-817  0.302
1982 Morishima Y, Ogata S, Collins NH, Dupont B, Lloyd KO. Carbohydrate differences in human high molecular weight antigens of B- and T-cell lines. Immunogenetics. 15: 529-535. PMID 6179863 DOI: 10.1007/Bf00345912  0.358
1982 de Sousa M, Pollack MS, Munn G, da Silva BM, Dupont B. Association of HLA phenotype with individual variations in ferritin secretion by activated human mononuclear cells Human Immunology. 5: 174. DOI: 10.1016/0198-8859(82)90119-7  0.379
1982 Pollack MS, Safai B, Myskowski PL, Dupont B. Association of HLA-DR5 with mycosis fungoides and kaposi's sarcoma Human Immunology. 5: 164-165. DOI: 10.1016/0198-8859(82)90102-1  0.32
1982 Pollack MS, Kirkpatrick D, Kapoor N, Evans R, Dupont B, O'Reilly RJ. HLA typing of lymphocyte subpopulations for the identification of intrauterine-derived engrafted maternal cells in patients with severe combined immunodeficiency (SCID) Human Immunology. 5: 163. DOI: 10.1016/0198-8859(82)90100-8  0.559
1982 Naito K, Morishima Y, Dupont B. Antigens on human T cell leukemia not present on thymocytes Human Immunology. 5: 161-162. DOI: 10.1016/0198-8859(82)90097-0  0.415
1982 Flomenberg N, Kornbluth J, Dupont B. MLC generated NK activity is mediated by a population of cells distinct from alloreactive T cells Human Immunology. 5: 150. DOI: 10.1016/0198-8859(82)90077-5  0.38
1982 Duffy EM, Collins NH, Dupont B. Comparison of class I and class II HLA antigens as targets for in vitro activated T lymphocytes Human Immunology. 5: 145-146. DOI: 10.1016/0198-8859(82)90070-2  0.382
1981 Christiansen FT, Kim SJ, Silver DM, Dupont B. Cytotoxic effector cells against HLA antigens in strong linkage disequilibrium: identification of a strong, new CML determinant. Human Immunology. 2: 15-29. PMID 7275696 DOI: 10.1016/0198-8859(81)90003-3  0.31
1981 Sorell M, Kapoor N, Kirkpatrick D, Rosen JF, Chaganti RS, Lopez C, Dupont B, Pollack MS, Terrin BN, Harris MB, Vine D, Rose JS, Goossen C, Lane J, Good RA, et al. Marrow transplantation for juvenile osteopetrosis. The American Journal of Medicine. 70: 1280-7. PMID 7015858 DOI: 10.1016/0002-9343(81)90839-1  0.533
1981 Kornbluth J, Silver DM, Dupont B. Cloning and characterization of primary alloreactive human T-lymphocytes. Immunological Reviews. 54: 111-55. PMID 6166533 DOI: 10.1111/J.1600-065X.1981.Tb00436.X  0.343
1981 Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Dupont B, Good RA, O'Reilly RJ. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (London, England). 2: 327-31. PMID 6115110 DOI: 10.1016/S0140-6736(81)90647-4  0.438
1981 Levine LS, Kohn B, Pollack M, Pang S, Levy D, Rondanini G, Lorenzen F, Dupont B, New MI. Late-Onset, Cryptic and Classical 21-OH Deficiency: Allelic Variants Pediatric Research. 15: 1558-1558. DOI: 10.1203/00006450-198112000-00139  0.357
1980 DeWolf WC, Dupont B, Yunis EJ. HLA and disease: current concepts. Human Pathology. 11: 332-336. PMID 6773876 DOI: 10.1016/S0046-8177(80)80028-1  0.365
1980 Pollack MS, Livingston PO, Fogh J, Carey TE, Oettgen HF, Dupont B. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. Tissue Antigens. 15: 249-56. PMID 6451045 DOI: 10.1111/J.1399-0039.1980.TB00915.X  0.314
1980 Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O'Reilly RJ. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation. 30: 331-4. PMID 6450472 DOI: 10.1097/00007890-198011000-00004  0.537
1980 Pollack MS, Ochs H, Schafer I, Barford D, Dupont B. HLA typing of cultured amniotic cells for the prenatal diagnosis of complement C4 deficiency and the identification of paternity Human Immunology. 1: 277-278. DOI: 10.1016/0198-8859(80)90069-5  0.335
1980 Pollack M, Heagney S, Fogh J, Livingston P, Oettgen H, Dupont B. HLA-A, B, C and DR alloantigens of 44 cultured human tumor cell lines Human Immunology. 1: 275-276. DOI: 10.1016/0198-8859(80)90066-X  0.34
1980 Kornbluth J, Dupont B. Functional characterization of primary alloreactive human T-lymphocytes Human Immunology. 1: 267. DOI: 10.1016/0198-8859(80)90052-X  0.326
1980 Kim SJ, Christiansen FT, Gosar I, Silver DM, Pollack MS, Dupont B. Antibodies reacting exclusively with PHA-activated T lymphocytes Human Immunology. 1: 266. DOI: 10.1016/0198-8859(80)90051-8  0.332
1980 Christiansen FT, Kim SJ, Silver DM, Dupont B. A new HLA-linked CML locus Human Immunology. 1: 251-252. DOI: 10.1016/0198-8859(80)90029-4  0.337
1979 Pollack MS, Yang SY, O'Neill GJ, O'Reilly RJ, Grossbard E, Kapoor N, Good RA, Dupont B. Bone marrow transplantation using typing for glyoxalase I as a tool in histocompatibility testing. Transplantation. 28: 156-8. PMID 384622 DOI: 10.1097/00007890-197908000-00019  0.408
1979 Schendel DJ, Wank R, Dupont B. Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic lymphocytes. European Journal of Immunology. 8: 634-40. PMID 152205 DOI: 10.1002/eji.1830080906  0.31
1979 Wank R, Schendel DJ, Blanco ME, Dupont B. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants. Scandinavian Journal of Immunology. 9: 499-505. PMID 88755 DOI: 10.1111/j.1365-3083.1979.tb03277.x  0.313
1979 Williams RM, Martin S, Falchuk KR, Trey C, Dubey DP, Cannady WG, Fitzpatrick D, Noreen H, Dupont B, Yunis EJ. Increased frequency of HLA-DRW4 in chronic active hepatitis. Vox Sanguinis. 35: 366-9. PMID 85369 DOI: 10.1111/J.1423-0410.1978.Tb02948.X  0.338
1978 Levine LS, Zachmann M, New MI, Prader A, Pollack MS, O'Neill GJ, Yang SY, Oberfield SE, Dupont B. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. The New England Journal of Medicine. 299: 911-5. PMID 692595 DOI: 10.1056/Nejm197810262991702  0.37
1978 Lieberman E, Rösler A, Cohen T, Moses S, Sack J, Benderli A, Landau H, Cohen I, Levine C, Levine L, Dupont B, New M, Brautbar C. Absence Of Linkage Between C-11 Oh Deficient Congenital Adrenal Hyperplasia And Hla Pediatric Research. 12: 1088. DOI: 10.1203/00006450-197811000-00043  0.341
1977 Hansen GS, Dupont B, Faber V, Jakobsen BK, Juhl F, Nielsen LS, Svejgaard A, Thomsen M, Wiik A. Lymphocyte chimerism after bone marrow transplantation. Surface markers and in vitro function of donor and recipient lymphocyte subpopulations. Scandinavian Journal of Immunology. 6: 299-303. PMID 323963 DOI: 10.1111/j.1365-3083.1977.tb00397.x  0.349
1977 O'Reilly RJ, Dupont B, Pahwa S, Grimes E, Smithwick EM, Pahwa R, Schwartz S, Hansen JA, Siegal FP, Sorell M, Svejgaard A, Jersild C, Thomsen M, Platz P, L'Esperance P, et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. The New England Journal of Medicine. 297: 1311-8. PMID 21351 DOI: 10.1056/Nejm197712152972403  0.533
1977 Case DJ, Hansen J, Corrales E, Young C, Dupont B, Pinsky C, Good R. Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions Blood. 49: 771-778. DOI: 10.1182/Blood.V49.5.771.771  0.386
1976 Case DC, Hansen JA, Corrales E, Young CW, Dupont B, Pinsky CM, Good RA. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease. Cancer. 38: 1807-15. PMID 1086708 DOI: 10.1002/1097-0142(197610)38:4<1807::Aid-Cncr2820380458>3.0.Co;2-Y  0.377
1976 Cunningham-Rundles C, Jersild C, Svejgaard A, Dupont B, Good RA. Evidence for tryosine peptide homologies in the HLA antigens system. Proceedings of the National Academy of Sciences of the United States of America. 72: 5081-5. PMID 1061093 DOI: 10.1073/Pnas.72.12.5081  0.377
1976 Whitsett C, Turner WJ, Lee TD, Dupont B. HLA antigen frequencies in paralytic dementia. Journal of the Neurological Sciences. 30: 417-420. PMID 1003256 DOI: 10.1016/0022-510X(76)90145-3  0.33
1976 Thompson JS, Braun WE, Carpenter CB, Dossetor JB, Dupont B, Falk JA, Ferrone S, Johnson AH, Shaw JF, Singal DP, Terasaki TI, Troup GM, Walford RL. Summary report on the second New World B-cell workshop. Tissue Antigens. 8: 355-7. PMID 65026 DOI: 10.1111/J.1399-0039.1976.Tb00587.X  0.311
1976 O'Reilly RJ, Everson LK, Emödi G, Hansen J, Smithwick EM, Grimes E, Pahwa S, Pahwa R, Schwartz S, Armstrong D, Siegal FP, Gupta S, Dupont B, Good RA. Effects of exogenous interferon in cytomegalovirus infections complicating bone marrow transplantation. Clinical Immunology and Immunopathology. 6: 51-61. PMID 7372 DOI: 10.1016/0090-1229(76)90060-X  0.513
1976 Cunningham-Rundles C, Jersild C, Dupont B, Good RA. Tyrosine Peptide Homologies in the HLA Antigen System Leukocyte Membrane Determinants Regulating Immune Reactivity. 535. DOI: 10.1016/B978-0-12-233750-5.50102-0  0.386
1976 Braunstein JD, Melamed MR, Hansen JA, Dupont B, Sharpless TK, Good RA. Quantitation Of Lymphocyte Blast Transformation By Flow Cytofluorometry Leukocyte Membrane Determinants Regulating Immune Reactivity. 533. DOI: 10.1016/B978-0-12-233750-5.50101-9  0.332
1975 Gorski AJ, Dupont B, Hansen JA, Good RA. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro Proceedings of the National Academy of Sciences of the United States of America. 72: 3197-3200. PMID 1103141 DOI: 10.1073/Pnas.72.8.3197  0.31
1974 Dupont B, Good RA, Hansen GS, Jersild C, Nielsen LS, Park BH, Svejgaard A, Thomsen M, Yunis EJ. Two separate genes controlling stimulation in mixed lymphocyte reaction in man. Proceedings of the National Academy of Sciences of the United States of America. 71: 52-6. PMID 4129803 DOI: 10.1073/Pnas.71.1.52  0.306
1972 Dupont B, Jersild C, Jakobsen B. Elimination of non-viable cells by DNase treatment prior to lymphocytotoxicity test. Tissue Antigens. 2: 141-4. PMID 4562355 DOI: 10.1111/J.1399-0039.1972.Tb00129.X  0.317
Show low-probability matches.